Monthly Prescribing Reference4d
Symvess, a Novel Treatment for Vascular Trauma, Gets FDA Approval
The single-use product is surgically implanted for arterial replacement and repair after a traumatic injury to the extremity.
FDA approval propels North Carolina company's breakthrough treatment for trauma patients
A Durham company secured federal approval for its bioengineered tissue, which could become a revolutionary treatment for ...
Nasdaq8d
Humacyte, Inc. Announces FDA Approval for SYMVESS as First-in-Class Bioengineered Vascular Conduit for Arterial Injury Repair
SYMVESS demonstrated high rates of patency and low rates of amputation and infection in clinical testing, showcasing its potential to improve patient outcomes in vascular trauma care. The company ...